| |
|
|
|
Alpine Immune Sciences Inc.  
|
|
2.79 -0.11 (-0.04%) |
10-16 15:58 |
|
Open: |
2.8364 |
Pre close: |
2.9 |
Target:
|
5.05
|
|
High: |
2.99 |
Low: |
2.78 |
Resistance:
|
4.32
5.34
|
|
Volume: |
4,225 |
Market Cap: |
52M |
Support:
|
2.68
2.23
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.86
 |
MACD |
MACD(12,26):
|
-0.39 |
|
MA(20): |
3.49 |
Signal(12,26,9): |
-0.35 |
|
MA(100): |
4.19 |
Stochastic Oscillator |
%K(14,3):
|
12.30 |
|
MA(250): |
5.18 |
%D(3): |
12.14  |
|
Average Volume(K) |
3-Month: |
1518
|
52-Week |
High:
|
8.24 |
|
10-Days: |
1433 |
Low: |
2.68 |
|
RSI |
RSI(14):
|
33.57 |
Change(%): |
-46.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.971 |
Return on Equity (ttm) |
-84.9 |
Shares Out. (M) |
18.59 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-42.5 |
Shares Float (M) |
3.92 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
39.78 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
45.4 |
% Held by Institutions |
46.54 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
-1.521 |
Shares Short (K) |
23 |
|
Book Value (p.s.) |
2.440 |
EBITDA (p.s.) |
-2.594 |
P/E |
-0.94 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.14 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-35.87 |
P/S |
1296652544.00 |
|
Operating Margin |
-8585.18 |
Levered Free Cash Flow
(M) |
-18.60 |
P/CF |
-1.45 |
|
|
|
|
|
|
